Viz.ai aims to use artificial intelligence and deep learning to automatically identify suspected LVOs (large vessel occlusion) on CTA imaging with the aim of alerting a patient's physician within minutes. The company was founded in 2016 and is based in San Francisco, California.
viz.aiWe’re invested, just like you
Step
Search and select the company in which you hold private shares.
Step
If Linqto wants to buy them, we’ll show you our offer price per share.
Step
Simply create an account, finalize and submit your sell order. Our team will contact you to handle all the closing details.